InvestorsHub Logo
Followers 274
Posts 53887
Boards Moderated 3
Alias Born 08/16/2008

Re: Ubertino post# 13769

Thursday, 01/12/2017 10:16:20 AM

Thursday, January 12, 2017 10:16:20 AM

Post# of 40503
INO So now the hope here is effectiveness won't be an issue for approval, LOL.
Like a boat that leaks but they are "intriguing" to look at on the water or a "food" with no nutritional value but make an "intriguing" presentation on the dinner table.
There is no end to the promotional pieces about and from Inovio- everything but results. Thirty three years and nothing approved but hundreds and hundreds and hundreds of promotional articles from this "company" run by a Director, the one who was a penny stock promoter.
The Inovio story is devolving into comedy.


If effectiveness isn't an issue, this DNA vaccine maker is grossly undervaluedInovio Pharmaceuticals is striving to bring the first DNA-based vaccine

or immunotherapy to market in the United States.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News